骨科产能升级！迈瑞全球制造布局再下一城

Core Viewpoint - The article highlights the establishment and significance of the Dazhang Mindray Medical Technology Industrial Park, which will serve as Mindray's fourth global manufacturing base, focusing on orthopedic products and contributing to local economic development [1][5][6]. Group 1: Project Overview - The Dazhang Mindray Medical Technology Industrial Park officially commenced construction on April 28, 2022, demonstrating efficient project execution with a timeline of just one and a half years from planning to implementation [3]. - Upon completion, the industrial park will produce high-specification bone screws that meet human implant standards and provide core components for other bases, enhancing Mindray's global supply chain [3][6]. Group 2: Employment and Economic Impact - As of 2024, the first phase of the Dazhang base has been completed and is in production, employing over 130 new staff, with total employment exceeding 200. Additionally, over 300 local employees have been hired for construction and administrative services [5]. - Mindray's chairman, Li Xiting, stated that the construction of the Dazhang base will propel the region into an era of industrial aggregation, accelerating local economic development [5]. Group 3: Global Supply Chain Layout - In 2022, Mindray upgraded its global supply chain, establishing five major manufacturing bases, including the Dazhang base, which will work synergistically with other bases to optimize global supply-demand matching and resource allocation [6]. - Mindray's products span three main areas: life information and support, in vitro diagnostics, and medical imaging, with a sales network covering over 190 countries and regions [6]. Group 4: Financial Performance - For the fiscal year 2024, Mindray reported total revenue of 36.73 billion yuan, a year-on-year increase of 5.1%, and a net profit attributable to shareholders of 11.67 billion yuan, reflecting a growth of 0.7% [10]. - The operating cash flow net amount reached 12.43 billion yuan, marking a 12.4% increase year-on-year [10]. Group 5: Orthopedic Product Layout - Mindray's orthopedic business includes the research, production, and sales of orthopedic implants, minimally invasive surgical equipment, and related high-value consumables, with over 120 varieties and more than 20,000 specifications [11]. - Recent product launches include hip joint ceramic products and spinal PEEK fusion devices, and the acquisition of Wuhan Degao Bayer has further enriched Mindray's orthopedic product line [11]. Group 6: Market Expansion and Procurement - Mindray actively participates in national and provincial alliance organizations for centralized procurement, achieving significant results in various procurement packages, including orthopedic trauma products and artificial joints [15].